Association between PIK3CA activating mutations and outcomes in early-stage invasive lobular breast carcinoma treated with adjuvant systemic therapy

Association between PIK3CA activating mutations and outcomes in early-stage invasive lobular breast carcinoma treated with adjuvant systemic therapy

The aim of the study was to evaluate the independent prognostic role of PIK3CA activating mutations and an association between PIK3CA activating mutations and efficacy of adjuvant endocrine therapy (ET) in patients with operable invasive lobular carcinoma (ILC).

Bibliographic Details
Main Authors: Ribnikar Domen, Horvat Valentina Jeric, Ratosa Ivica, Veitch Zachary W, Grcar Kuzmanov Biljana, Novakovic Srdjan, Langerholc Erik, Amir Eitan, Seruga Bostjan
Format: Article
Language:English
Published: Sciendo 2023-06-01
Series:Radiology and Oncology
Subjects:
invasive lobular carcinoma
pik3ca mutation
endocrine therapy
genomics of invasive lobular carcinoma
Online Access:https://doi.org/10.2478/raon-2023-0027

Internet

https://doi.org/10.2478/raon-2023-0027

Similar Items